China Universal Asset Management Company’s Corvus Pharmaceuticals CRVS Stock Holding History

China Universal Asset Management Company’s Portfolio CRVS Stock Details CRVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$62K	Buy
2025 Q1	$41K	Sell
2024 Q4	$72.9K	Buy
2022 Q4	–	Sell
2022 Q3	$0	Buy